Wells Fargo analyst Larry Biegelsen raised the firm’s price target on Stryker to $364 from $336 and keeps an Overweight rating on the shares. The firm notes Q4 sales and EPS handily beat expectations and 2024 guidance of 7.5%-9.0% organic sales growth and EPS of $11.70-$12.00 was introduced. The midpoint of the EPS guidance is well above consensus, Wells adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SYK: